Summary:
Click image to enlarge
You may qualify for a clinical research study to test the effectiveness of a new investigational drug for the treatment of relapsed or refractory chronic lymphocytic leukemia (CLL).
Chronic lymphocytic leukemia is the second most common type of leukemia in adults, often occurring after middle age.
Qualifications Include:
- Adults ages 18 and older
- Diagnosis of chronic lymphocytic leukemia (CLL)
- Not currently undergoing chemotherapy, radiotherapy, immunotherapy, biologic, investigational, or hormonal therapy for the treatment of lymphoma
- Prior unsuccessful chemotherapy treatment. ‘Unsuccessful’ meaning a return of the cancer or lack of response to the treatment
Participants who qualify for this study may receive all study related care and study drug at no cost.
Study is available at:
Click here for a list of study site locations.
To find out more about this study, please click here.
By visiting the website and completing the questionnaire, we will determine if you are a match for this study or another within our CLL matching database.